Ancillary Symposium: Keeping Sight of Thyroid Eye Disease

This program is a 60-minute virtual webinar including live Q&A that will be available on-demand on Endocrine Society's Center for Learning platform.

This program was funded through educational grants from Horizon Therapeutics.

The webinar and recording will include a pre-survey, post-assessment, evaluation, and follow-up survey, and will be certified for up to 1 AMA PRA Category 1 Credit and 1 ABIM MOC Point.

Registrants of this program prior to the event date will automatically be registered for the live webinar and will be sent login information 24-48 hours before the event. If you are unable to attend the live webinar, the recording will be available within 5-10 business days.

Learning Objectives

Upon successful completion of the activities, participants should be better able to:

  • Describe the basic pathophysiology of Graves’ disease and thyroid eye disease.
  • Analyze early signs and symptoms of thyroid eye disease, including criteria for stratifying mild, moderate, and severe disease, and determinants of disease activity.
  • Evaluate new and emerging biological agents for treatment of thyroid eye disease.

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Thyroid/HPT Axis
Level of Outcomes: 
Level 3A (Learning: Declarative Knowledge (Knows))
Activity summary
Course opens: 
09/07/2020
Course expires: 
12/31/2022
Rating: 
5

Program

The program will focus on clinical presentations on state of care, challenges, and emerging therapies of Thyroid Eye Disease. Topics covered will include:  

  • Overview of Thyroid Eye Disease Pathophysiology 
  • Clinical Features: Improving Diagnosis 
  • Current and Emerging Therapeutic Landscape 
  • Question and Answer 
Chair:  
Terry J. Smith, MD 

Frederick G.L. Huetwell Professor 
Ophthalmology and Visual Sciences 
Professor of Internal Medicine 
University of Michigan Medical School 
Ann Arbor, Michigan 

Speaker:  
Don O. Kikkawa, MD 

Chief, Division of Oculofacial Plastic and Reconstructive Surgery 
Professor of Ophthalmology 
Vice-Chairman, Department of Ophthalmology 
University of California San Diego 
La Jolla, CA

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Don O. Kikkawa, MD: Consultant, Horizon Therapeutics; Book Royalties, Elsevier Publishing
Terry J. Smith, MD:  Consultant, Novartis, Merck, Lithera, Immunovant, River Vision, Horizon Therapeutics

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships:
Angela M. Leung, MD: Speaker, Medical Education Resources, MCE Conferences

The following SPC Committee members reported relevant financial relationships:
Andjela T. Drincic, MD: Advisory Board Member, Corcept
Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Akcea, Aegerion, Esperion, Novartis
Amy Rothberg, MD: Spouse, consultant of Merck

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:
Katherine Araque, MD; Beret Ann Casey, MD; Jenny Blau, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD;Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

 

The staff involved in the development of this CME activity reported no relevant financial relationships.

DISCLAIMERS

USE OF PROFESSIONAL JUDGMENT:

The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

DRUGS AND DOSAGES:

When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

This educational activity is supported by an independent medical educational grant from Horizon Therapeutics.

Click "Start" to complete the meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.  

The Endocrine Society designates the webinar will be certified for up to 1 AMA PRA Category 1 Credits and 1 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   For questions about content or obtaining CME credit, please contact the Endocrine Society at education.endocrine.org/contact. 

MAINTENANCE OF CERTIFICATION 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, for each webinar. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

REVIEW YOUR DIPLOMATE ABIM ID NUMBER(S)
In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

  1. Provide your board-certification information in your educational profile.  Your profile currently contains the following board ID numbers (must be logged in to view):
    Your ABIM Number: [current-user:profile-profile:field-number-abim]*

    *If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.
     
  2. Update Profile